{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:11:00Z","timestamp":1784311860769,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12931-017-0501-5","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T07:03:54Z","timestamp":1486105434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-0739","authenticated-orcid":false,"given":"Giles","family":"Dixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Lama-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver J.","family":"Bintcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J.","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare E.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"issue":"Suppl 2","key":"501_CR1","doi-asserted-by":"publisher","first-page":"ii41","DOI":"10.1136\/thx.2010.137000","volume":"65","author":"British Thoracic Society Pleural Disease Group","year":"2010","unstructured":"British Thoracic Society Pleural Disease Group. Management of pleural infection in adults: British thoracic society pleural disease guideline 2010. Thorax. 2010;65 Suppl 2:ii41\u201353. doi: 10.1136\/thx.2010.137000 .","journal-title":"Thorax"},{"issue":"7","key":"501_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1164\/rccm.200601-074OC","volume":"174","author":"NA Maskell","year":"2006","unstructured":"Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174(7):817\u201323. doi: 10.1164\/rccm.200601-074OC .","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"501_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/qjmed\/89.4.285","volume":"89","author":"AD Ferguson","year":"1996","unstructured":"Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM. 1996;89(4):285\u20139.","journal-title":"QJM"},{"issue":"4","key":"501_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MCP.0b013e328352c673","volume":"18","author":"CL Tobin","year":"2012","unstructured":"Tobin CL, Lee YC. Pleural infection: what we need to know but don\u2019t. Curr Opin Pulm Med. 2012;18(4):321\u20135. doi: 10.1097\/MCP.0b013e328352c673 .","journal-title":"Curr Opin Pulm Med"},{"issue":"12","key":"501_CR5","doi-asserted-by":"publisher","first-page":"e49894","DOI":"10.1371\/journal.pone.0049894","volume":"7","author":"FJ McCann","year":"2012","unstructured":"McCann FJ, Chapman SJ, Yu WC, Maskell NA, Davies RJ, Lee YC. Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings. Plos One. 2012;7(12):e49894. doi: 10.1371\/journal.pone.0049894 .","journal-title":"Plos One"},{"issue":"6","key":"501_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1183\/09031936.00197208","volume":"34","author":"JM Porcel","year":"2009","unstructured":"Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-Onzalez A, Martinez-Iribarren A, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J. 2009;34(6):1383\u20139. doi: 10.1183\/09031936.00197208 .","journal-title":"Eur Respir J"},{"issue":"15","key":"501_CR7","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.clinbiochem.2013.03.018","volume":"46","author":"SH Lee","year":"2013","unstructured":"Lee SH, Lee EJ, Min KH, Hur GY, Kim JH, Shin C, et al. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Clin Biochem. 2013;46(15):1484\u20138. doi: 10.1016\/j.clinbiochem.2013.03.018 .","journal-title":"Clin Biochem"},{"issue":"8844","key":"501_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","volume":"341","author":"M Assicot","year":"1993","unstructured":"Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515\u20138.","journal-title":"Lancet"},{"issue":"5\u20136","key":"501_CR9","first-page":"373","volume":"57","author":"M Botana-Rial","year":"2011","unstructured":"Botana-Rial M, Casado-Rey P, Leiro-Fernandez V, Andrade-Olivie M, Represas-Represas C, Fernandez-Villar A. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion. Clin Lab. 2011;57(5\u20136):373\u20138.","journal-title":"Clin Lab"},{"issue":"Suppl 2","key":"501_CR10","doi-asserted-by":"publisher","first-page":"ii4","DOI":"10.1136\/thx.2010.136978","volume":"65","author":"British Thoracic Society Pleural Disease Group","year":"2010","unstructured":"British Thoracic Society Pleural Disease Group. Investigation of a unilateral pleural effusion in adults: British thoracic society pleural disease guideline 2010. Thorax. 2010;65 Suppl 2:ii4\u2013ii17. doi: 10.1136\/thx.2010.136978 .","journal-title":"Thorax"},{"issue":"7379","key":"501_CR11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bmj.326.7379.41","volume":"326","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ. 2003;326(7379):41\u20134.","journal-title":"BMJ"},{"issue":"6","key":"501_CR12","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1086\/514793","volume":"28","author":"A Viallon","year":"1999","unstructured":"Viallon A, Zeni F, Lambert C, Pozzetto B, Tardy B, Venet C, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis. 1999;28(6):1313\u20136. doi: 10.1086\/514793 .","journal-title":"Clin Infect Dis"},{"issue":"1","key":"501_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1378\/chest.06-1500","volume":"131","author":"D Stolz","year":"2007","unstructured":"Stolz D, Christ-Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9\u201319. doi: 10.1378\/chest.06-1500 .","journal-title":"Chest"},{"issue":"4","key":"501_CR14","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1378\/chest.128.4.2223","volume":"128","author":"M Masia","year":"2005","unstructured":"Masia M, Gutierrez F, Shum C, Padilla S, Navarro JC, Flores E, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest. 2005;128(4):2223\u20139. doi: 10.1378\/chest.128.4.2223 .","journal-title":"Chest"},{"issue":"1","key":"501_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1378\/chest.08-1134","volume":"136","author":"MC Lin","year":"2009","unstructured":"Lin MC, Chen YC, Wu JT, Ko YC, Wang CC. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions. Chest. 2009;136(1):205\u201311.","journal-title":"Chest"},{"issue":"8","key":"501_CR16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2310\/JIM.0b013e3181f88648","volume":"58","author":"ME San","year":"2010","unstructured":"San ME, Valdes L, Vizcaino LH, Mora T, Pose A, Soneira E, et al. Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions. J Investig Med. 2010;58(8):971\u20136.","journal-title":"J Investig Med"},{"issue":"9713","key":"501_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463\u201374.","journal-title":"Lancet"},{"issue":"3","key":"501_CR18","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/cc7903","volume":"13","author":"M Hochreiter","year":"2009","unstructured":"Hochreiter M, Kohler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13(3):R83.","journal-title":"Crit Care"},{"issue":"2","key":"501_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00003643-200102000-00004","volume":"18","author":"M Meisner","year":"2001","unstructured":"Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol. 2001;18(2):79\u201387.","journal-title":"Eur J Anaesthesiol"},{"issue":"4","key":"501_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/CCM.0b013e3181692966","volume":"36","author":"J Amour","year":"2008","unstructured":"Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med. 2008;36(4):1147\u201354. doi: 10.1097\/CCM.0b013e3181692966 .","journal-title":"Crit Care Med"},{"issue":"5 Pt 1","key":"501_CR21","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1164\/ajrccm.160.5.9903002","volume":"160","author":"CW Davies","year":"1999","unstructured":"Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1682\u20137. doi: 10.1164\/ajrccm.160.5.9903002 .","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"501_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.amjmed.2007.10.033","volume":"121","author":"JD Chalmers","year":"2008","unstructured":"Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008;121(3):219\u201325. doi: 10.1016\/j.amjmed.2007.10.033 .","journal-title":"Am J Med"},{"issue":"9","key":"501_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJMoa042473","volume":"352","author":"NA Maskell","year":"2005","unstructured":"Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352(9):865\u201374. doi: 10.1056\/NEJMoa042473 .","journal-title":"N Engl J Med"},{"issue":"8","key":"501_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/thx.2010.157842","volume":"66","author":"SM Menzies","year":"2011","unstructured":"Menzies SM, Rahman NM, Wrightson JM, Davies HE, Shorten R, Gillespie SH, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax. 2011;66(8):658\u201362. doi: 10.1136\/thx.2010.157842 .","journal-title":"Thorax"},{"issue":"6","key":"501_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2217\/fmb.14.143","volume":"10","author":"JM Marimon","year":"2015","unstructured":"Marimon JM, Morales M, Cilla G, Vicente D, Perez-Trallero E. Detection of bacteria and viruses in pleural effusion of children and adults with community-acquired pneumonia. Future Microbiol. 2015;10(6):909\u201315. doi: 10.2217\/fmb.14.143 .","journal-title":"Future Microbiol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-017-0501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:41:24Z","timestamp":1498369284000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-017-0501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1186\/s12931-017-0501-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,3]]},"article-number":"30"}}